Please enable JavaScript to continue using this application.

Compare $IMVT vs $PRAX | Chartloom

Compare

$IMVT vs $PRAX

Immunovant Inc · Praxis Precision Medicines Inc

IMVT

Immunovant Inc

PRAX

Praxis Precision Medicines Inc

Compare $IMVT vs $PRAX

Comparing Immunovant Inc and Praxis Precision Medicines Inc

IMVTImmunovant Inc

PRAXPraxis Precision Medicines Inc

IMVTImmunovant Inc

Market cap

$6.29B

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

—

Rev growth (TTM)

—

YTD performance

17.6%

52W performance

89.5%

FCF yield

-6.6%

PRAXPraxis Precision Medicines Inc

Market cap

$7.24B

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

67.04x

Rev growth (TTM)

—

YTD performance

-9.3%

52W performance

378.7%

FCF yield

-4.2%

Add ticker

Add up to 1 more ticker to compare

Relative performance

Each ticker starts at 100. 110 means +10% from the start of this window — not a $110 share price.

IMVT

PRAX

Detailed metrics comparison

IMVT

Immunovant Inc

PRAX

Praxis Precision Medicines Inc

Market Cap

IMVT$6.29B

PRAX$7.24B

Enterprise Value

IMVT$5.49B

PRAX$6.77B

Price

IMVT$30.47

PRAX$259.86

P/E Ratio

IMVTN/A

PRAXN/A

P/S Ratio

IMVT0.00x

PRAX964.65x

EV/Sales

IMVT0.00x

PRAX909.14x

EV/EBITDA

IMVT0.00x

PRAX0.00x

P/B Ratio

IMVT9.44x

PRAX6.15x

P/FCF Ratio

IMVTN/A

PRAXN/A

EV/FCF

IMVT-13.25x

PRAX-22.11x

PEG Ratio

IMVTN/A

PRAXN/A

Forward P/E (NTM)

IMVTN/A

PRAXN/A

Forward P/S (NTM)

IMVTN/A

PRAX67.04x

Revenue (TTM)

IMVT$0

PRAX$0

Revenue Growth (YoY)

IMVTN/A

PRAXN/A

Forward Rev Growth

IMVT546.2%

PRAX38349.0%

Gross Margin (TTM)

IMVT0.0%

PRAX0.0%

Operating Margin (TTM)

IMVT0.0%

PRAX0.0%

EBITDA Margin (TTM)

IMVT0.0%

PRAX0.0%

Net Margin (TTM)

IMVT0.0%

PRAX0.0%

FCF Margin (TTM)

IMVTN/A

PRAXN/A

Net Income (TTM)

IMVT$-538M

PRAX$-255M

FCF (TTM)

IMVT$-414M

PRAX$-306M

EPS (TTM)

IMVT-$2.62

PRAX$0.00

ROE (TTM)

IMVT-6959.0%

PRAX-4302.0%

ROA (TTM)

IMVT-6250.0%

PRAX-4022.0%

ROIC (TTM)

IMVT-6959.0%

PRAX-4302.0%

Cash

IMVT$798M

PRAX$475M

Debt

IMVT$0

PRAX$0

Net Cash/Debt

IMVT$798M

PRAX$475M

Current Ratio (TTM)

IMVT7.27x

PRAX15.73x

Quick Ratio (TTM)

IMVT6.82x

PRAX15.46x

Debt/Equity (TTM)

IMVT0.00x

PRAX0.00x

Debt/Assets (TTM)

IMVT0.0%

PRAX0.0%

Interest Coverage (TTM)

IMVTN/A

PRAXN/A

Net Debt/EBITDA (TTM)

IMVT0.00x

PRAX0.00x

Beta

IMVT0.92

PRAX2.88

52W Performance

IMVT89.5%

PRAX378.7%

YTD Performance

IMVT17.6%

PRAX-9.3%

% from 52W High

IMVT-32.9%

PRAX-33.8%

% from 52W Low

IMVT89.5%

PRAX414.0%

Asset Turnover (TTM)

IMVT0.00x

PRAX0.02x

FCF Yield (TTM)

IMVT-6.6%

PRAX-4.2%

Earnings Yield (TTM)

IMVT-8.6%

PRAX-3.5%

Dividend Yield (TTM)

IMVTN/A

PRAXN/A

Rule of 40

IMVT0.0

PRAX0.0

EV/GP/RG

IMVTN/A

PRAXN/A

Ticker research

View IMVT research View PRAX research

Metric	IMVT Immunovant Inc	PRAX Praxis Precision Medicines Inc
Market & Valuation
Market Cap	$6.29B	$7.24B
Enterprise Value	$5.49B	$6.77B
Price	$30.47	$259.86
P/E Ratio	N/A	N/A
P/S Ratio	0.00x	964.65x
EV/Sales	0.00x	909.14x
EV/EBITDA	0.00x	0.00x
P/B Ratio	9.44x	6.15x
P/FCF Ratio	N/A	N/A
EV/FCF	-13.25x	-22.11x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	N/A	67.04x
Revenue & Growth
Revenue (TTM)	$0	$0
Revenue Growth (YoY)	N/A	N/A
Forward Rev Growth	546.2%	38349.0%
Profitability
Gross Margin (TTM)	0.0%	0.0%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	0.0%	0.0%
Net Margin (TTM)	0.0%	0.0%
FCF Margin (TTM)	N/A	N/A
Net Income (TTM)	$-538M	$-255M
FCF (TTM)	$-414M	$-306M
EPS (TTM)	-$2.62	$0.00
ROE (TTM)	-6959.0%	-4302.0%
ROA (TTM)	-6250.0%	-4022.0%
ROIC (TTM)	-6959.0%	-4302.0%
Financial Health
Cash	$798M	$475M
Debt	$0	$0
Net Cash/Debt	$798M	$475M
Current Ratio (TTM)	7.27x	15.73x
Quick Ratio (TTM)	6.82x	15.46x
Debt/Equity (TTM)	0.00x	0.00x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	0.92	2.88
52W Performance	89.5%	378.7%
YTD Performance	17.6%	-9.3%
% from 52W High	-32.9%	-33.8%
% from 52W Low	89.5%	414.0%
Efficiency & Yields
Asset Turnover (TTM)	0.00x	0.02x
FCF Yield (TTM)	-6.6%	-4.2%
Earnings Yield (TTM)	-8.6%	-3.5%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	0.0	0.0
EV/GP/RG	N/A	N/A
Ticker research	View IMVT research	View PRAX research

Valuation

P/S Ratio

IMVT

0.00x

PRAX

964.65x

EV/FCF

PRAX

-22.11x

IMVT

-13.25x

Growth & revenue

Forward Revenue Growth

PRAX

38349.0%

IMVT

546.2%

Profitability & performance

Gross Margin

IMVT

0.0%

PRAX

0.0%

ROE

PRAX

-4302.0%

IMVT

-6959.0%

FCF Yield %

PRAX

-4.2%

IMVT

-6.6%

52-Week Performance

PRAX

378.7%

IMVT

89.5%

Detailed metrics comparison

IMVT

Immunovant Inc

PRAX

Praxis Precision Medicines Inc

Market Cap

IMVT$6.29B

PRAX$7.24B

Enterprise Value

IMVT$5.49B

PRAX$6.77B

Price

IMVT$30.47

PRAX$259.86

P/E Ratio

IMVTN/A

PRAXN/A

P/S Ratio

IMVT0.00x

PRAX964.65x

EV/Sales

IMVT0.00x

PRAX909.14x

EV/EBITDA

IMVT0.00x

PRAX0.00x

P/B Ratio

IMVT9.44x

PRAX6.15x

P/FCF Ratio

IMVTN/A

PRAXN/A

EV/FCF

IMVT-13.25x

PRAX-22.11x

PEG Ratio

IMVTN/A

PRAXN/A

Forward P/E (NTM)

IMVTN/A

PRAXN/A

Forward P/S (NTM)

IMVTN/A

PRAX67.04x

Revenue (TTM)

IMVT$0

PRAX$0

Revenue Growth (YoY)

IMVTN/A

PRAXN/A

Forward Rev Growth

IMVT546.2%

PRAX38349.0%

Gross Margin (TTM)

IMVT0.0%

PRAX0.0%

Operating Margin (TTM)

IMVT0.0%

PRAX0.0%

EBITDA Margin (TTM)

IMVT0.0%

PRAX0.0%

Net Margin (TTM)

IMVT0.0%

PRAX0.0%

FCF Margin (TTM)

IMVTN/A

PRAXN/A

Net Income (TTM)

IMVT$-538M

PRAX$-255M

FCF (TTM)

IMVT$-414M

PRAX$-306M

EPS (TTM)

IMVT-$2.62

PRAX$0.00

ROE (TTM)

IMVT-6959.0%

PRAX-4302.0%

ROA (TTM)

IMVT-6250.0%

PRAX-4022.0%

ROIC (TTM)

IMVT-6959.0%

PRAX-4302.0%

Cash

IMVT$798M

PRAX$475M

Debt

IMVT$0

PRAX$0

Net Cash/Debt

IMVT$798M

PRAX$475M

Current Ratio (TTM)

IMVT7.27x

PRAX15.73x

Quick Ratio (TTM)

IMVT6.82x

PRAX15.46x

Debt/Equity (TTM)

IMVT0.00x

PRAX0.00x

Debt/Assets (TTM)

IMVT0.0%

PRAX0.0%

Interest Coverage (TTM)

IMVTN/A

PRAXN/A

Net Debt/EBITDA (TTM)

IMVT0.00x

PRAX0.00x

Beta

IMVT0.92

PRAX2.88

52W Performance

IMVT89.5%

PRAX378.7%

YTD Performance

IMVT17.6%

PRAX-9.3%

% from 52W High

IMVT-32.9%

PRAX-33.8%

% from 52W Low

IMVT89.5%

PRAX414.0%

Asset Turnover (TTM)

IMVT0.00x

PRAX0.02x

FCF Yield (TTM)

IMVT-6.6%

PRAX-4.2%

Earnings Yield (TTM)

IMVT-8.6%

PRAX-3.5%

Dividend Yield (TTM)

IMVTN/A

PRAXN/A

Rule of 40

IMVT0.0

PRAX0.0

EV/GP/RG

IMVTN/A

PRAXN/A

Ticker research

View IMVT research View PRAX research

Metric	IMVT Immunovant Inc	PRAX Praxis Precision Medicines Inc
Market & Valuation
Market Cap	$6.29B	$7.24B
Enterprise Value	$5.49B	$6.77B
Price	$30.47	$259.86
P/E Ratio	N/A	N/A
P/S Ratio	0.00x	964.65x
EV/Sales	0.00x	909.14x
EV/EBITDA	0.00x	0.00x
P/B Ratio	9.44x	6.15x
P/FCF Ratio	N/A	N/A
EV/FCF	-13.25x	-22.11x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	N/A	67.04x
Revenue & Growth
Revenue (TTM)	$0	$0
Revenue Growth (YoY)	N/A	N/A
Forward Rev Growth	546.2%	38349.0%
Profitability
Gross Margin (TTM)	0.0%	0.0%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	0.0%	0.0%
Net Margin (TTM)	0.0%	0.0%
FCF Margin (TTM)	N/A	N/A
Net Income (TTM)	$-538M	$-255M
FCF (TTM)	$-414M	$-306M
EPS (TTM)	-$2.62	$0.00
ROE (TTM)	-6959.0%	-4302.0%
ROA (TTM)	-6250.0%	-4022.0%
ROIC (TTM)	-6959.0%	-4302.0%
Financial Health
Cash	$798M	$475M
Debt	$0	$0
Net Cash/Debt	$798M	$475M
Current Ratio (TTM)	7.27x	15.73x
Quick Ratio (TTM)	6.82x	15.46x
Debt/Equity (TTM)	0.00x	0.00x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	0.92	2.88
52W Performance	89.5%	378.7%
YTD Performance	17.6%	-9.3%
% from 52W High	-32.9%	-33.8%
% from 52W Low	89.5%	414.0%
Efficiency & Yields
Asset Turnover (TTM)	0.00x	0.02x
FCF Yield (TTM)	-6.6%	-4.2%
Earnings Yield (TTM)	-8.6%	-3.5%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	0.0	0.0
EV/GP/RG	N/A	N/A
Ticker research	View IMVT research	View PRAX research